Thus, we infused non-expanded autologous TALs along with weekly IL2 support into 099-CL-Luc tumor-bearing N-HSGM3 mice and tested therapeutic efficacy either alone or in combination with ICB (figure 5A). Here, IL2 is linked to neoplasm.